Arkolith/Insider Trading/LENZ/Form 4

Versant Vantage II GP-GP, LLC

10% OwnerLENZ Therapeutics, Inc. (LENZ) · full profile →Form 4 · filed Jun 12, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10.2M
Net Open-Market Flow
-$10.2M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 10, 2025Sell(S)350K$29.00$10.2M1.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-085490) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML